MaaT Pharma Secures €37.5 Million Loan From European Investment Bank (EIB) Marking a New Step…
MaaT PharmaJuly 28, 2025
MaaT Pharma: Half-year Report to the Liquidity Contract With Kepler Cheuvreux Lyon, France, July 24,…
MaaT PharmaJuly 24, 2025
Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital…
MaaT PharmaJuly 7, 2025
MaaT Pharma Announces Exclusive Commercialization Partnership With Clinigen for Xervyteg® in acute Graft-versus Host Disease…
MaaT PharmaJuly 2, 2025
